Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPR35 is an orphan GPCR with high expression in immune/gastrointestinal tissues. It modulates inflammation through complex mechanisms that can be either pro-or anti-inflammatory based on cellular context. Its involvement extends into cardiovascular regulation and cancer biology—making it a promising therapeutic target despite challenges related to ligand specificity/species selectivity among tool compounds currently available for research use.
GPR35 activation induces conformational change leading to activation of associated heterotrimeric G proteins. Downstream signaling influences immune cell activation/chemotaxis/cytokine production or suppression depending on cellular context. Modulates angiogenesis within tumor microenvironments.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G-protein Coupled Receptor 35 (GPR35).